Dangers
Related to Psychotropic Drugs
by Dr. Josh Axe
Today, psychotropic medications are the most widely
prescribed drugs in America! A great deal of evidence has suggested that
psychotropic drugs do not make you better, but in fact, can make you worse.
Below are common dangers related to psychotropic drugs.
PSYCHOTROPIC
DRUGS
Psychotropic
drugs affect your mood, behavior and perception by changing the way your brain
functions. The drugs mainly target the central nervous system by leaving the blood
and entering the brain. They are prescribed for various symptoms and diseases
that include but are not limited to anxiety, depression, bipolar disorder,
attention deficit disorder (ADD), attention deficit hyperactivity disorder
(ADHD) and schizophrenia.
Specifically,
the antidepressants known as selective serotonin reuptake inhibitors (SSRIs)
are used to correct low levels of serotonin in the brain, which has been
suggested to be a “chemical imbalance.” Many patients believe they have this
“chemical imbalance” that requires medication, such as Zoloft. However, science
has failed to prove this serotonin theory do to lack of conclusive evidence1.
In 2005, the president of the American Psychological Association, Stephen
Sharfstein, said that there is no evidence to prove that chemical imbalances
are related to mental disorders2.
In
addition, psychotropic drugs have been shown to cause serious side effects,
such as diabetes, heart disease, miscarriages, weight gain and suicidal
thoughts in children and adolescents, to name a few. As of 2008, a total of
63,000 people had committed suicide while taking SSRIs2. Interestingly enough,
these SSRIs were known back in the 1980s to cause violent behaviors and
suicidal thoughts before they even went on the market to be sold!
The
primary side effect that you should be concerned about is that antidepressants
can actually increase your risk of suicide, and your risk for type 2 diabetes
is two to three times higher if you take antidepressants. Antidepressants,
including tricyclic and SSRIs, increase type 2 diabetes risk.
Side
note about diet and depression: a recent University of
London study, led by Dr. Eric Brunner, followed the eating habits of 3,486
adults for 5 years. The study revealed that those who ate diets high in
processed and fast foods were almost 60% more likely to suffer from depression.
DIABETES
New
onset diabetes has been found in individuals taking psychotropic drugs with no
previous medical history of diabetes. Individuals were diagnosed on average
three to six months after starting psychotropic medication. The likelihood of
developing diabetes is up to ten times higher in individuals taking
psychotropic drugs compared to individuals not on the medications3.
HEART
DISEASE
Researchers
found a link between psychotropic drug usage and sudden cardiac death. This
could be in part due to the dosage, the toxins in the drugs and/or underlying
cardiac risk. When taking psychotropic drugs, sudden cardiac death is more
likely to occur in the individuals as risk for cardiac disease when compared to
their healthy counterparts4. Additionally, psychotropic drugs have been shown
to cause less drastic cardiac problems, such as irregular heartbeat and high
blood pressure that occur in patients with no cardiac risk prior to consumption
of the drug5.
PREGNANCY
Researchers
have suggested that pregnant women with anxiety or depression are more likely
to have a miscarriage or perinatal death when taking psychotropic drugs during
their first trimester when compared to women who did not take the drugs6.
Another study found similar results with pregnant women twice as likely to have
a miscarriage or spontaneous abortion and three times as likely for the baby to
have abnormalities if prescribed a psychotropic drug during the first trimester7.
There have also been reports that pregnant women exposed to the SSRI Paxil were
twice as likely to have babies with major birth defects, primarily heart
malformations8-9.
WEIGHT
GAIN
If
overweight or obese, weight gain can lead to fatal disorders, such as diabetes
and heart disease. One study compared over 660 clinical trials and determined
that weight gain was associated with psychotropic drug use10. Unfortunately,
the amount of weight gain could not be determined due to the vast number of
studies compared. However, it was concluded that weight gain was more likely in
individuals with previous psychotropic drug exposure.
CHILDREN
AND ADOLESCENTS
The
number of psychotropic drugs prescribed to adolescents between the ages of 14
and 18 increased 250% from 1994 to 200111. A randomized control trial
looking at 1,000 individuals found that children taking a SSRI or children that
recently stopped taking a SSRI were almost three times more likely to commit
suicide (3.4%) than those taking the placebo (1.2%)12. Similar results showed
that children prescribed antidepressants were twice as likely to commit suicide
than children not prescribed psychotropic drugs13.
In
regards to depression, a number of studies found that SSRIs did not improve
depressive symptoms in children when compared to the placebo group14-15. The
sad truth is that not only do psychotropic drugs potentially increase suicide
in children, but there is little evidence to suggest that they even help the
symptoms.
Action
Steps
There
are usually many underlying causes to mental challenges or dysfunctions,
emotionally and physically, and can stem from lifestyle. Some causes can be a
lack of Vitamin D, Vitamin B12, too much salt or sugar in your diet, not eating
enough healthy fats like Omega-3′s, lack of sleep, and
lack of exercise.
Remember,
drugs should be your last choice. If you or your child is suffering from
an emotional or mental challenge, please do seek help, but I recommend finding
a professional who does not prescribe psychotropic drugs as a first, or only,
form of defense.
If
you or your children are taking psychotropic drugs, I strongly urge you to
educate yourself and work with your physician to seek alternative options.
Instead of dangerous medications, first seek counseling and truly address the
root cause of any depression or behavioral disorder. Also address other dietary
and lifestyle issues like Omega-3 and niacin deficiencies, mercury toxicity and
lack of exercise.
REFERENCES
1.
Lacasse, J. R., and J. Leo. “Serotonin and Depression: A Disconnect between the
Advertisements and the Scientific Literature.” PLoS medicine 2.12
(2005): e392. Print.
2.
CCHR: Exposing the Dangers of Antidepressants and Other Psychotropic
Drugs—Despite FDA/Psychiatric-Pharmaceutical Cover-Ups. CCHR Report. 2008.
3.
Sharav, V. H. “Children in Clinical Research: A Conflict of Moral Values.” The
American journal of bioethics : AJOB 3.1 (2003): W,IF 2. Print.
4.
Timour, Q., et al. “Sudden Death of Cardiac Origin and Psychotropic
Drugs.” Frontiers in pharmacology 3 (2012): 76. Print.
5.
Marano, G., et al. “Cardiologic Side Effects of Psychotropic
Drugs.” Journal of geriatric cardiology : JGC 8.4 (2011): 243-53.
Print.
6.
Ban, L., et al. “Live and Non-Live Pregnancy Outcomes among Women with
Depression and Anxiety: A Population-Based Study.” PloS one 7.8
(2012): e43462. Print.
7.
Prozac: Child Abuse, CCHR Report, 1994.
8.
Benedict Carey, “Paxil Alert for Pregnant Women,” The New York Times, 29
September, 2005; Miranda Hitti,
9.
“New Study Links Paxil to Twice as Many Birth Defects as Other
Antidepressants,” WebMD Medical News, 27 Sept. 2005.
10.
Dent, R., et al. “Changes in Body Weight and Psychotropic Drugs: A Systematic
Synthesis of the Literature.” PloS one 7.6 (2012): e36889. Print.
11.
“DTC Ads Linked to Rise in Drug ‘Scripts for Teens,” Psychiatric Times, Apr.
2006, Vol. XXIII, No. 4.
12.
Dave Altimari, Memos Display Drug Firms’ Optimism Officials Were Confident FDA
Would Back Them On Suicide, Violence Issues Involving Paxil, Prozac,” Hartford
Courant, 21 Sept. 2003.
13.
Anna Wilde Mathews, “FDA Will Seek to Revise Antidepressant Labels for Youth,”
The Wall Street Journal, 20 Aug. 2004; Gardiner Harris, “Antidepressant Study
Seen to Back Expert,” The New York Times, 20 Aug. 2004.
14.
Gardiner Harris, “Antidepressant Study Seen to Back Expert,” The New York
Times, 20 Aug. 2004.
15.
Joe Barton, Chairman, U.S. House of Representatives, Committee on Energy and
Commerce, website, 24 Mar. 2004
No comments:
Post a Comment
PLEASE ADD COMMENTS SO I CAN IMPROVE THE INFORMATION I AM SHARING ON THIS VERY IMPORTANT TOPIC.